Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration

Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW (2000)
JOURNAL OF NEUROSCIENCE 20(21): 7964-7971.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Abstract / Bemerkung
ADAM proteases, defined by extracellular disintegrin and metalloprotease domains, are involved in protein processing and cell-cell interactions. Using wobbler (WR) mutant mice, we investigated the role of ADAMs in neurodegeneration and reactive glia activation in the CNS. We found that ADAM8 (CD 156), a suspected leukocyte adhesion molecule, is expressed in the CNS and highly induced in affected CNS areas of WR mice, in brainstem and spinal cord. ADAM8 mRNA and protein are found at low levels throughout the normal mouse CNS, in neurons and oligodendrocytes. In the WR CNS regions in which neurodegeneration occurs, ADAM8 is induced in neurons, reactive astrocytes, and activated microglia. Similarly, the proinflammatory cytokine tumor necrosis factor alpha (TN-alpha) is upregulated and shows the same cellular distribution. In primary astrocytes from wild-type and WR mice, in primary cerebellar neurons, and in mouse motoneuron-like NSC19 cells, ADAM8 expression was induced up to 15-fold by mouse TNF-alpha, in a dose-dependent manner. In both cell types, ADAM8 was also induced by human TNF-alpha, indicating that TNF receptor type I (p55) is involved. Induction of ADAM8 mRNA was suppressed by treatment with an interferon-regulating factor 1 (IRF-1) antisense oligonucleotide. We conclude that IRF-1-mediated induction of ADAM8 by TNF-alpha is a signaling pathway relevant for neurodegenerative disorders with glia activation, proposing a role for ADAM8 in cell adhesion during neurodegeneration.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF NEUROSCIENCE
Band
20
Ausgabe
21
Seite(n)
7964-7971
ISSN
PUB-ID

Zitieren

Schlomann U, Rathke-Hartlieb S, Yamamoto S, Jockusch H, Bartsch JW. Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration. JOURNAL OF NEUROSCIENCE. 2000;20(21):7964-7971.
Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., & Bartsch, J. W. (2000). Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration. JOURNAL OF NEUROSCIENCE, 20(21), 7964-7971.
Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., and Bartsch, J. W. (2000). Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration. JOURNAL OF NEUROSCIENCE 20, 7964-7971.
Schlomann, U., et al., 2000. Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration. JOURNAL OF NEUROSCIENCE, 20(21), p 7964-7971.
U. Schlomann, et al., “Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration”, JOURNAL OF NEUROSCIENCE, vol. 20, 2000, pp. 7964-7971.
Schlomann, U., Rathke-Hartlieb, S., Yamamoto, S., Jockusch, H., Bartsch, J.W.: Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration. JOURNAL OF NEUROSCIENCE. 20, 7964-7971 (2000).
Schlomann, U, Rathke-Hartlieb, S, Yamamoto, S, Jockusch, Harald, and Bartsch, JW. “Tumor necrosis factor a induces a metalloprotease-disintegrin, ADAM8 (CD 156): Implications for neuron-glia interactions during neurodegeneration”. JOURNAL OF NEUROSCIENCE 20.21 (2000): 7964-7971.

61 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Significantly altered peripheral blood cell DNA methylation profile as a result of immediate effect of metformin use in healthy individuals.
Elbere I, Silamikelis I, Ustinova M, Kalnina I, Zaharenko L, Peculis R, Konrade I, Ciuculete DM, Zhukovsky C, Gudra D, Radovica-Spalvina I, Fridmanis D, Pirags V, Schiöth HB, Klovins J., Clin Epigenetics 10(1), 2018
PMID: 30545422
Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.
Mthembu NN, Mbita Z, Hull R, Dlamini Z., HIV AIDS (Auckl) 9(), 2017
PMID: 28694706
The metalloproteinase ADAM8 promotes leukocyte recruitment in vitro and in acute lung inflammation.
Dreymueller D, Pruessmeyer J, Schumacher J, Fellendorf S, Hess FM, Seifert A, Babendreyer A, Bartsch JW, Ludwig A., Am J Physiol Lung Cell Mol Physiol 313(3), 2017
PMID: 28596294
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression.
Theodorou K, van der Vorst EPC, Gijbels MJ, Wolfs IMJ, Jeurissen M, Theelen TL, Sluimer JC, Wijnands E, Cleutjens JP, Li Y, Jansen Y, Weber C, Ludwig A, Bentzon JF, Bartsch JW, Biessen EAL, Donners MMPC., Sci Rep 7(1), 2017
PMID: 28916789
ADAM8 as a drug target in pancreatic cancer.
Schlomann U, Koller G, Conrad C, Ferdous T, Golfi P, Garcia AM, Höfling S, Parsons M, Costa P, Soper R, Bossard M, Hagemann T, Roshani R, Sewald N, Ketchem RR, Moss ML, Rasmussen FH, Miller MA, Lauffenburger DA, Tuveson DA, Nimsky C, Bartsch JW., Nat Commun 6(), 2015
PMID: 25629724
Comparative analysis of gingival crevicular fluid a disintegrin and metalloproteinase 8 levels in health and periodontal disease: A clinic-biochemical study.
Elavarasu S, Suthanthiran T, Thangavelu A, Saravanan J, Selvaraj S, Mohandas L., J Pharm Bioallied Sci 7(suppl 2), 2015
PMID: 26538900
The selective glucocorticoid receptor modulator CORT108297 restores faulty hippocampal parameters in Wobbler and corticosterone-treated mice.
Meyer M, Gonzalez Deniselle MC, Hunt H, de Kloet ER, De Nicola AF., J Steroid Biochem Mol Biol 143(), 2014
PMID: 24565565
Amelioration of LPS-induced inflammation response in microglia by AMPK activation.
Chen CC, Lin JT, Cheng YF, Kuo CY, Huang CF, Kao SH, Liang YJ, Cheng CY, Chen HM., Biomed Res Int 2014(), 2014
PMID: 25025067
Expression of A disintegrin and metalloprotease 8 is associated with cell growth and poor survival in colorectal cancer.
Yang Z, Bai Y, Huo L, Chen H, Huang J, Li J, Fan X, Yang Z, Wang L, Wang J., BMC Cancer 14(), 2014
PMID: 25098630
Elevated levels of a disintegrin and metalloproteinase 8 in gingival crevicular fluid of patients with periodontal diseases.
Khongkhunthian S, Techasatian P, Supanchart C, Bandhaya P, Montreekachon P, Thawanaphong S, Krisanaprakornkit S., J Periodontol 84(4), 2013
PMID: 22612366
Adam8 limits the development of allergic airway inflammation in mice.
Knolle MD, Nakajima T, Hergrueter A, Gupta K, Polverino F, Craig VJ, Fyfe SE, Zahid M, Permaul P, Cernadas M, Montano G, Tesfaigzi Y, Sholl L, Kobzik L, Israel E, Owen CA., J Immunol 190(12), 2013
PMID: 23670189
Src plays a key role in ADAM28 expression in v-src-transformed epithelial cells and human carcinoma cells.
Abe H, Mochizuki S, Ohara K, Ueno M, Ochiai H, Kitagawa Y, Hino O, Sato H, Okada Y., Am J Pathol 183(5), 2013
PMID: 24007880
ADAM8 in asthma. Friend or foe to airway inflammation?
Chen J, Jiang X, Duan Y, Long J, Bartsch JW, Deng L., Am J Respir Cell Mol Biol 49(6), 2013
PMID: 23837412
Cellular prion protein regulates its own α-cleavage through ADAM8 in skeletal muscle.
Liang J, Wang W, Sorensen D, Medina S, Ilchenko S, Kiselar J, Surewicz WK, Booth SA, Kong Q., J Biol Chem 287(20), 2012
PMID: 22447932
The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo.
Zhou L, Barão S, Laga M, Bockstael K, Borgers M, Gijsen H, Annaert W, Moechars D, Mercken M, Gevaert K, De Strooper B., J Biol Chem 287(31), 2012
PMID: 22692213
Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degeneration.
De Paola M, Mariani A, Bigini P, Peviani M, Ferrara G, Molteni M, Gemma S, Veglianese P, Castellaneta V, Boldrin V, Rossetti C, Chiabrando C, Forloni G, Mennini T, Fanelli R., Mol Med 18(), 2012
PMID: 22562723
ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation.
Paulissen G, Rocks N, Guéders MM, Bedoret D, Crahay C, Quesada-Calvo F, Hacha J, Bekaert S, Desmet C, Foidart JM, Bureau F, Noel A, Cataldo DD., Eur J Immunol 41(2), 2011
PMID: 21268008
Regulating inflammation: ADAM8--a new player in the game.
Zarbock A, Rossaint J., Eur J Immunol 41(12), 2011
PMID: 22125009
ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice.
Guaiquil VH, Swendeman S, Zhou W, Guaiquil P, Weskamp G, Bartsch JW, Blobel CP., J Mol Med (Berl) 88(5), 2010
PMID: 20119708
ADAM8 is selectively up-regulated in endothelial cells and is associated with angiogenesis after spinal cord injury in adult mice.
Mahoney ET, Benton RL, Maddie MA, Whittemore SR, Hagg T., J Comp Neurol 512(2), 2009
PMID: 19003792
ADAM8 and its single nucleotide polymorphism 2662 T/G are associated with advanced atherosclerosis and fatal myocardial infarction: Tampere vascular study.
Levula M, Airla N, Oksala N, Hernesniemi JA, Pelto-Huikko M, Salenius JP, Zeitlin R, Järvinen O, Huovila AP, Nikkari ST, Jaakkola O, Ilveskoski E, Mikkelsson J, Perola M, Laaksonen R, Kytömäki L, Soini JT, Kähönen M, Parkkinen J, Karhunen PJ, Lehtimäki T., Ann Med 41(7), 2009
PMID: 19575316
ADAM8: a new therapeutic target for asthma.
Knolle MD, Owen CA., Expert Opin Ther Targets 13(5), 2009
PMID: 19397475
ADAM8 substrate specificity: influence of pH on pre-processing and proteoglycan degradation.
Hall T, Pegg LE, Pauley AM, Fischer HD, Tomasselli AG, Zack MD., Arch Biochem Biophys 491(1-2), 2009
PMID: 19766586
Recombinant human TNF-binding protein-1 (rhTBP-1) treatment delays both symptoms progression and motor neuron loss in the wobbler mouse.
Bigini P, Repici M, Cantarella G, Fumagalli E, Barbera S, Cagnotto A, De Luigi A, Tonelli R, Bernardini R, Borsello T, Mennini T., Neurobiol Dis 29(3), 2008
PMID: 18201889
Transcriptome analyses in normal prostate epithelial cells exposed to low-dose cadmium: oncogenic and immunomodulations involving the action of tumor necrosis factor.
Bakshi S, Zhang X, Godoy-Tundidor S, Cheng RY, Sartor MA, Medvedovic M, Ho SM., Environ Health Perspect 116(6), 2008
PMID: 18560533
Increased expression of ADAM33 and ADAM8 with disease progression in asthma.
Foley SC, Mogas AK, Olivenstein R, Fiset PO, Chakir J, Bourbeau J, Ernst P, Lemière C, Martin JG, Hamid Q., J Allergy Clin Immunol 119(4), 2007
PMID: 17339047
ADAMs in cancer cell proliferation and progression.
Mochizuki S, Okada Y., Cancer Sci 98(5), 2007
PMID: 17355265
ADAM8 expression is associated with increased invasiveness and reduced patient survival in pancreatic cancer.
Valkovskaya N, Kayed H, Felix K, Hartmann D, Giese NA, Osinsky SP, Friess H, Kleeff J., J Cell Mol Med 11(5), 2007
PMID: 17979891
Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.
Naus S, Reipschläger S, Wildeboer D, Lichtenthaler SF, Mitterreiter S, Guan Z, Moss ML, Bartsch JW., Biol Chem 387(3), 2006
PMID: 16542157
The ADAMs family: coordinators of nervous system development, plasticity and repair.
Yang P, Baker KA, Hagg T., Prog Neurobiol 79(2), 2006
PMID: 16824663
Implication of ADAM-8, -9, -10, -12, -15, -17, and ADAMTS-1 in implantational remodeling of a mouse uterus.
Kim J, Kang SG, Kim JI, Park JH, Kim SK, Cho DJ, Kim H., Yonsei Med J 47(4), 2006
PMID: 16941747
Metalloprotease-induced ectodomain shedding of neural cell adhesion molecule (NCAM).
Hinkle CL, Diestel S, Lieberman J, Maness PF., J Neurobiol 66(12), 2006
PMID: 16967505
ADAM8 expression in prostate cancer is associated with parameters of unfavorable prognosis.
Fritzsche FR, Jung M, Xu C, Rabien A, Schicktanz H, Stephan C, Dietel M, Jung K, Kristiansen G., Virchows Arch 449(6), 2006
PMID: 17106710
Metalloprotease-disintegrin ADAM8: expression analysis and targeted deletion in mice.
Kelly K, Hutchinson G, Nebenius-Oosthuizen D, Smith AJ, Bartsch JW, Horiuchi K, Rittger A, Manova K, Docherty AJ, Blobel CP., Dev Dyn 232(1), 2005
PMID: 15580619
Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.
Dave KR, Raval AP, Purroy J, Kirkinezos IG, Moraes CT, Bradley WG, Pérez-Pinzón MA., Neurobiol Dis 18(1), 2005
PMID: 15649703
Two novel isoforms of Adam23 expressed in the developmental process of mouse and human brains.
Sun YP, Deng KJ, Wang F, Zhang J, Huang X, Qiao S, Zhao S., Gene 325(), 2004
PMID: 14697522
ADAM proteins in the brain.
Novak U., J Clin Neurosci 11(3), 2004
PMID: 14975408
Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.
King NE, Zimmermann N, Pope SM, Fulkerson PC, Nikolaidis NM, Mishra A, Witte DP, Rothenberg ME., Am J Respir Cell Mol Biol 31(3), 2004
PMID: 15087305
Tomoregulin ectodomain shedding by proinflammatory cytokines.
Lin H, Wada K, Yonezawa M, Shinoki K, Akamatsu T, Tsukui T, Sakamoto C., Life Sci 73(13), 2003
PMID: 12875894
The wobbler mouse: a neurodegeneration jigsaw puzzle.
Boillée S, Peschanski M, Junier MP., Mol Neurobiol 28(1), 2003
PMID: 14514986
Developmental regulation and neuronal expression of the cellular disintegrin ADAM11 gene in mouse nervous system.
Rybnikova E, Kärkkäinen I, Pelto-Huikko M, Huovila AP., Neuroscience 112(4), 2002
PMID: 12088751
Progressive loss of striatal neurons causes motor dysfunction in MND2 mutant mice and is not prevented by Bcl-2.
Rathke-Hartlieb S, Schlomann U, Heimann P, Meisler MH, Jockusch H, Bartsch JW., Exp Neurol 175(1), 2002
PMID: 12009762
The many faces of tumor necrosis factor in stroke.
Hallenbeck JM., Nat Med 8(12), 2002
PMID: 12457181
Metalloproteinases in biology and pathology of the nervous system.
Yong VW, Power C, Forsyth P, Edwards DR., Nat Rev Neurosci 2(7), 2001
PMID: 11433375

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 11050116
PubMed | Europe PMC

Suchen in

Google Scholar